These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 16729287)

  • 1. Anti-interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled study.
    Straub RH; Härle P; Yamana S; Matsuda T; Takasugi K; Kishimoto T; Nishimoto N
    Arthritis Rheum; 2006 Jun; 54(6):1778-85. PubMed ID: 16729287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion.
    Straub RH; Pongratz G; Schölmerich J; Kees F; Schaible TF; Antoni C; Kalden JR; Lorenz HM
    Arthritis Rheum; 2003 Jun; 48(6):1504-12. PubMed ID: 12794817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis.
    Straub RH; Paimela L; Peltomaa R; Schölmerich J; Leirisalo-Repo M
    Arthritis Rheum; 2002 Mar; 46(3):654-62. PubMed ID: 11920401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of pregnenolone and 17-hydroxypregnenolone in patients with rheumatoid arthritis and systemic lupus erythematosus: relation to other adrenal hormones.
    Vogl D; Falk W; Dorner M; Schölmerich J; Straub RH
    J Rheumatol; 2003 Feb; 30(2):269-75. PubMed ID: 12563679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible role of leptin in hypoandrogenicity in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Härle P; Pongratz G; Weidler C; Büttner R; Schölmerich J; Straub RH
    Ann Rheum Dis; 2004 Jul; 63(7):809-16. PubMed ID: 15194576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex hormone concentrations in patients with rheumatoid arthritis are not normalized during 12 weeks of anti-tumor necrosis factor therapy.
    Straub RH; Härle P; Atzeni F; Weidler C; Cutolo M; Sarzi-Puttini P
    J Rheumatol; 2005 Jul; 32(7):1253-8. PubMed ID: 15996060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased DHEAS levels in patients with rheumatoid arthritis after treatment with tumor necrosis factor antagonists: evidence for improved adrenal function.
    Ernestam S; Hafström I; Werner S; Carlström K; Tengstrand B
    J Rheumatol; 2007 Jul; 34(7):1451-8. PubMed ID: 17477470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenal plasma steroid relations in glucocorticoid-naïve premenopausal rheumatoid arthritis patients during insulin-induced hypoglycemia test compared to matched normal control females.
    Imrich R; Vigas M; Rovensky J; Aldag JC; Masi AT
    Endocr Regul; 2009 Apr; 43(2):65-73. PubMed ID: 19856711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic-pituitary-adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia rheumatica.
    Cutolo M; Foppiani L; Minuto F
    J Endocrinol Invest; 2002; 25(10 Suppl):19-23. PubMed ID: 12508908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids.
    Cutolo M; Foppiani L; Prete C; Ballarino P; Sulli A; Villaggio B; Seriolo B; Giusti M; Accardo S
    J Rheumatol; 1999 Feb; 26(2):282-8. PubMed ID: 9972959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replacement therapy with DHEA plus corticosteroids in patients with chronic inflammatory diseases--substitutes of adrenal and sex hormones.
    Straub RH; Schölmerich J; Zietz B
    Z Rheumatol; 2000; 59 Suppl 2():II/108-18. PubMed ID: 11155790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered function of the hypothalamic stress axes in patients with moderately active systemic lupus erythematosus. II. Dissociation between androstenedione, cortisol, or dehydroepiandrosterone and interleukin 6 or tumor necrosis factor.
    Zietz B; Reber T; Oertel M; Glück T; Schölmerich J; Straub RH
    J Rheumatol; 2000 Apr; 27(4):911-8. PubMed ID: 10782815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriatic arthritis: clinical improvement and correlation with hormone axes in etanercept-treated patients.
    Atzeni F; Straub RH; Cutolo M; Sarzi-Puttini P
    Ann N Y Acad Sci; 2010 Apr; 1193():176-8. PubMed ID: 20398026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor inhibits conversion of dehydroepiandrosterone sulfate (DHEAS) to DHEA in rheumatoid arthritis synovial cells: a prerequisite for local androgen deficiency.
    Weidler C; Struharova S; Schmidt M; Ugele B; Schölmerich J; Straub RH
    Arthritis Rheum; 2005 Jun; 52(6):1721-9. PubMed ID: 15934093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal clearance and daily excretion of cortisol and adrenal androgens in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Straub RH; Weidler C; Demmel B; Herrmann M; Kees F; Schmidt M; Schölmerich J; Schedel J
    Ann Rheum Dis; 2004 Aug; 63(8):961-8. PubMed ID: 15249323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infusion of epinephrine decreases serum levels of cortisol and 17-hydroxyprogesterone in patients with rheumatoid arthritis.
    Straub RH; Kittner JM; Heijnen C; Schedlowski M; Schmidt RE; Jacobs R
    J Rheumatol; 2002 Aug; 29(8):1659-64. PubMed ID: 12180725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial.
    Choy EH; Isenberg DA; Garrood T; Farrow S; Ioannou Y; Bird H; Cheung N; Williams B; Hazleman B; Price R; Yoshizaki K; Nishimoto N; Kishimoto T; Panayi GS
    Arthritis Rheum; 2002 Dec; 46(12):3143-50. PubMed ID: 12483717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenal function under long-term raloxifene administration.
    Genazzani AR; Lombardi I; Borgioli G; di Bono I; Casarosa E; Gambacciani M; Palumbo M; Genazzani AD; Luisi M
    Gynecol Endocrinol; 2003 Apr; 17(2):159-68. PubMed ID: 12737677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenocortical response to low-dose ACTH test in female patients with rheumatoid arthritis.
    Radikova Z; Rovensky J; Vlcek M; Penesova A; Kerlik J; Vigas M; Imrich R
    Ann N Y Acad Sci; 2008 Dec; 1148():562-6. PubMed ID: 19120158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.